A Comparison of Two Commercial ADAMTS13 Activity Assays With a Reference Laboratory Method [PDF]
Ronda A. Crist, George M. Rodgers
openalex +1 more source
Effect of early initation of Eculizumab in patients with aHUS on renal outcomes: a pooled analysis [PDF]
Ardissimo, Gianluigi+5 more
core
Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor
Clemens L. Bockmeyer+7 more
openalex +2 more sources
ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13); von Willebrand factor (VWF) [PDF]
openalex +1 more source
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. [PDF]
Ahmad+65 more
core +1 more source
Beyond the Limits of Conventional Coagulation Tests: A Comprehensive Overview of ACLF-Related Coagulopathies. [PDF]
Kurpiewska D+3 more
europepmc +1 more source
Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis [PDF]
Luis Fernando Bittar+5 more
openalex +1 more source
VWF-ADAMTS13 imbalance bridges infection to stroke. [PDF]
Dong JF, Han C.
europepmc +1 more source
The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura". [PDF]
Lämmle B.
europepmc +1 more source